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Inhibition of the formation of pro-inflammatory eicosanoids 
such as leukotrienes and 12-hydroxyeicosatetraenoic acid by 
15-hydroxyeicosatetraenoic acid (15-HETE) has been re-
ported. Psoriatic dermis synthesizes reduced levels of 15-
HETE and it has been postulated to playa role in the patho-
physiology of this disease. Interleukin-1 stimulates the 
production of prostaglandin E2 in fibroblasts, but its effect on 
the synthesis of 15-HETE is at present unknown. The aim of 
this study was to investigate the modulation of 15-HETE 
formation by interleukin-l in dermal fibroblasts. Cells were 
treated with recombinant interleukin-1a or P prior to incu-
bation with exogenous 14C-arachidonic acid, and eicosanoids 
were analyzed by HPLC. Interleukin-1 significantly in-
creased the production of 15-HETE, but also 12-hydroxy-
heptadecatrienoic acid, 11-hydroxyeicosatetraenoic acid, and 
prostaglandins, in a concentration- and time-dependent fash-
ion. No significant differences between the two types of 
L iPOXygenaSe_derived eicosanoids constitute a family of lipid mediators that have been described as playing a role in certain inflammatory skin diseases such as atopic der-matitis and psoriasis. In contrast with other eicosanoids such as leukotriene B4 (LTB4)' which are present in 
biologically active amounts from the beginning of the psoriatic 
lesion [1], the hydroxyeicosatetraenoic acids (HETEs) are present in 
significant quantities in fully developed chronic psoriatic lesions 
[1 - 3]. 12-hydroxyeicosatetraenoic acid (1 2-HETE) has strong pro-
inflammatory and leukocyte chemotactic activities [4 ,S], whereas 
some putative antiinflammatory properties of lS-HETE have been 
reported. 1S-HETE and its precursor 1S-hydroperoxyeicosate-
traenoic acid (1S-HPETE) are powerful inhibitors of S-lipoxygen-
ase [6 -9], 12-lipoxygenase [10,11], and cyclooxygenase [12] in 
vitro, which are involved in the biosynthesis of the pro-inflamma-
tory eicosanoids LTB4, 12-HETE, and PGE2 , respectively. 1S-
HETE also antagonizes the chemotactic effect ofLTB4 in vitro [13]. 
Moreover, intradermal injections of 1S-HETE into psoriatic lesions 
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interleukin-1 were found. Dexamethasone (10 nM), and the 
protein synthesis inhibitors actinomycin D (1 .uM) and cy-
cloheximide (3 .ug/ml) completely abolished the effect of 
interleukin-1 on 15-HETE formation. Whereas indometha-
cin (0.5 - 25 .uM) strongly inhibited the synthesis of 15-
HETE, aspirin (100-1000 .uM) was unable to significantly 
inhibit its formation in both untreated and interleukin-
treated fibroblasts. Aspirin inhibited the 15-HETE produced 
by cyclooxygenase from ram seminal vesicles, although to a 
lesser extent than indomethacin. In cell-free extracts, the 
activity concerning the synthesis of 15-HETE was associated 
with the microsomal fraction (100,000 X g pellet). Overall , 
these results strongly suggest that interleukin-1 increases 15-
HETE formation mainly through the expression of new cy-
clooxygenase. Key words: interleukin-1/eicosanoids/hydroxyei-
cosatetraenoic acids. ] Invest Dermatol1 02:98 -1 04, 1994 
provoke a partial improvement or even tota l reversal of them [14]. 
1S-HETE is one of the most abundant eicosanoids found in psoriatic 
lesions [3] . Although the dermis has a greater capacity than epider-
mis to form 1S-HETE [1S], it is a minor compound derived from 
arachidonic acid in fibroblasts and epidermal cells ill vitro [1 6-18}. 
It remains unclear what regulatory mechanisms can account for the 
high levels of 1S-HETE found in psoriatic lesions. Several partial 
contributions could explain this fact: a) the synthesis of lS-HETE 
by inflammatory infiltrating cells such as eosinophils that produce 
lS-HETE through the lS-lipoxygenase pathway [19,20]; b) a non-
specific accumulation of 1S-HETE (and other monohydroxy-fatty 
acids) in the surrounding area of its cellular origin due to their 
lipophilic nature"; c) the stimulation of the lS-HETE biosynthesis 
in skin cells by factors involved in the inflammatory process such as 
IL-1. 
Interleukin-1 (IL-l) is a pleiotropic cytokine that is preformed in 
human epidermis [21,22]. Dermal fibroblasts are able to respond to 
exogenous IL-l by secreting IL-lf1 and regulatory secondary cyto-
kines such as IL-6, IL-8, and granulocyte-macrophage colony stim-
ulating factor GM-CSF [23] . IL- l also stimulates the synthesis of 
PGE2 in this cel l type [24]. Raz et al [2S] and Korn et at [26]. among 
others, described that the effect ofIL-l On PGE2 synthesis by dermal 
fibroblasts was due to a direct effect on COX gene expression rather 
than the stimulation of phospholipase A2 activity. IL-l regulates the 
expression of the enzyme at a transcriptional level, by inducing the 
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synthesis of mRNA encoding COX [27]. Until now, there is scarce 
information concerning the effect of this cytokine on the regulation 
of lipoxygenases in general and 1S-LOX inrarticular [28] . Due to 
the fact that in psoriatic skin the levels 0 these two important 
mediators, IL-1 and lS-HETE, appear to be dysregulated [3,29J, we 
have explored in the present work the effect of IL-1", and IL-1p on 
the synthesis of lS-HETE by dermal fibroblasts. 
MATERIALS AND METHODS 
Cell Culture Human dermal fibroblasts were isolated from skin pieces 
from breast and abdomen, derived from women submitted to plastic surgery. 
Dermal fragments were separated from the epidermis according to the tech-
nique described by Liu and Karasek [30], and treated with 0.5 mg/ ml of 
collagenase type Ia (Sigma, St. Louis, MO) for 24 h at 37'C. The resulting 
cell suspension was cultured in 35-mm wells (Costar Europe, Badhoeve-
dorp, The Netherlands) in complete culture medium DMEM (Flow Labs, 
Irvine, Scotland) containing 10% fetal bovine serum, 2 mM glutamine, 
2 mM sodium pyruvate, 100 U /ml penicillin, 100 ,ug/ml streptomycin, and 
10 mM HEPES buffer (Flow Labs). Cells were always used between the 
fourth and tenth passage at confluence (5 - 7 X lOs cell/well). 
Effect of Arachidonic Acid Concentration on Eicosanoid Format-
ion The cells were incubated with 10 -200 ,uM I4C-arachidonic acid 
("C-AA, 56 mCi/mmol, Amersham, Buckinghamshire, U.K.) in 0.4 ml 
Dulbecco's minimum essential medium (DMEM) containing 10 mMHepes 
and 1 mM CaCI2. After 15 min at 37 ' C, the reaction was stopped by adding 
1 N HCI to yield pH 3.5 and an equal volume of cold methanol. Samples 
were kept at - 80' C until analyses were performed. 
Effect ofIncubation Time on the Metabolism of Exogenous Arachi-
donic Acid The cel ls were incubated with 25,uM "C-AA at 37 'C for 
several periods of time (1-20 min). Samples were afterwards processed as 
described above. 
Effect of Treatment with IL-l on the Metabolism of Arachidonic 
Acid The cells were incubated with several concentrations of human re-
combinant IL-l" or IL-Ip (0-20 U/ml; Boehringer Mannheim, GmbH, 
Germany). After 24 h, the medium was removed and the cells were incu-
bated with 25,uM 14C_AA for 15 min as described above. 
Effect of Time of Treatment with IL-t on the Arachidonic Acid 
Metabolism The cells were incubated in the presence ofl0 U/ ml ofIL-l 
from 0 to 24 h. The cells were then incubated with 25,uM I4C-AA for 
15 min as described above. 
Effect of the Inhibition of Protein Synthesis on the Action ofIL-l on 
Arachidonic Acid Metabolism The cells were incubated for 8 h with 
10 U /ml IL-lp in the presence or absence of3 ,ug/ml cycloheximide or I ,uM 
actinomycin. Fibroblasts were then incubated with 25,uM 14C_AA for 
IS min as described above. 
Effect of Dexamethasone on the Action ofIL-l on Arachidonic Acid 
Metabolism The cells were incubated for 8 h with IOU j mllL-l p in the 
presence or absence of 10 nM dexamethasone. Cells were then incubated 
with 25,uM "C-AA for 15 min as described above. 
Effect of CycIooxygenase and Lipoxygenase Inhibitors on the Ac-
tion of IL-l on Arachidonic Acid Metabolism Acetyl salicylic acid 
(ASA) and indomethacin were purchased from Sigma (St. Louis, MO), and 
5,8,11, 14-eicosatetraynoic acid (ETY A) was purchased from Paesel (Frank-
furt am Main, Germany). Following treatment in the presence and absence 
of10 U/ml IL-lp, cells were washed with DMEMand pre incubated at37 ' C 
with the indicated concentrations of the inhibitors dissolved in ethanol 
(0.1 % v jv final concentration). All inhibitors were added to the cells 10 min 
prior to "C-AA addition. When ASA was used, the incubation medium was 
removed after treatment with ASA and the cells were washed again, prior to 
addition of the substrate. None of these treatments affected cell viability 
«95%), assessed by Trypan blue exclusion. 
Incubations with Cell Fractions Fibroblasts were detached with 0.1 % 
trypsin in phosphate-buffered saline (PBS) pH 7.4 and washed twice by 
centrifugation at 600 X g for 10 min to remove trypsin. Cells were resus-
pended in 2-3 ml Tris HCI 50 mM, pH 7.4, plus a cocktail of protease 
inhibitors, and then disrupted mechanically. After centrifugation at 300 X g 
for 5 min, the supernatant was centrifuged at 100,000 X gat 4'C for 1 h. 
Supernatants and resuspended pellets (in the same Tris buffer) were then 
incubated with 50,uM "C_AA for 10 min as described above. Results are 
expressed as pmol of AA transformed in every compound per mg of protein. 
Protein determination was performed following Lowry's method (protein 
assay kit; Sigma Diagnostics, Deisenhofen, Germany). 
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Figure 1. Typical chromatogram s of analysis of the most polar eicosanoids 
in fibroblasts incubated with 25,uM 14C-AA at 37 'C for 15 min (F). Stan-
dards (S): 1, 6-keto-PGF t ,,; 2, PGF2a ; 3, PGE2 ; 4, PGD2; 5, HHT; 6, 
15-HETE; 7, 12-HETE; 8, 5-HETE. Chromatographic procedure: RP-
HPLC column, Ultrasphere-ODS, 250 X 4 mm (Beckman). Solvents: A, 
aceconitrile: water: acetic acid 33: 67; 0.01 ; B, acetonitrile: water: acetic 
acid 90: 10: 0.01; gradient, 100% A until minute 16 after injection; thereaf-
ter percentage of B was increased linearly to reach 65% 26 minutes after 
injection and then maintained until minute 45; flow, I mljmin. 
Incubations with Isolated Cyclooxygenase Cyclooxygenase isolated 
from ram seminal vesicles was supplied by Cayman Chemical Co (Ann 
Arbor, MI). Incubation mixture was composed by 64, 128, or 256 U of 
isolated cyclooxygenase, 2 mM phenol, 2 mM CaCI2, 10 mM HEPES, 
50 tiM I4C-AA, in 0.5 ml DMEM. The mixture was incubated at 37'C for 
5 min. Reactions were scopped and samples processed as indicated above. In 
the inhibition experiments the indicated inhibitors were preincubated for 
10 min before addition of I4C_AA. 
Sample Analysis 
RP-HPLC: Samples from incubations were directly injected into a C-18 
column and eicosanoids separated by high performance liquid chromatogra-
phy (HPLC) as previously described [18]. Peaks were identified by coelution 
with authentic standards and detected by means of an on line 171 Rad ioiso-
tope Detector provided with liquid scintillation cell. I1-HETE sta.ndard was 
detected by 235 nm absorption on a Beckman-165 UV detector. 
SP-HPLC: Parallel samples from incubations were extracted three times in 
a mixture of diethyl-ether: n-hexane (1 : 1) and evaporated under a N2 atmo-
sphere until dryness. Samples were redissolved in 250 ,ul of chromatographic 
eluent. The recovery of 15-HETE with this extraction procedure was 
72.38 ± 5.3; n = 5. Two hundred microliters of the samples were injected 
into a column (Ultrasphere-Si, 250 X 4 mm, 5 f.Lm spherical particle; Beck-
man, San Ramon, CAl. Isocratic elution was performed by a mixture of 
diethyl-ether: n-hexane: acetic acid, 30: 70: 0.1, at a 1 mljmin flow rate 
during 30 min. 
On some occasions, the peak corresponding to 15-HETE was collected 
from reverse phase (RP)-HPLC and evaporated until dryness under N2 
stream. The residue was redissolved in 250 ,ul of eluent, and 200,u1 of the 
sample was analyzed by straight phase (SP)-HPLC as described . 
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Figure 2. Typical chromatograms of analysis of the less polar compounds 
in fibroblasts incubated with 25 J.lM 14C_AA at 37"C for 15 min (F) , 
or 128 U of isolated cyclooxygenase from ram seminal vesicles incubated 
with 50 J.lM 14C_AA at 37"C for 5 min (C) . Standards (5): 1, HHT; 2, 
13 - HODE + 9 - HODE; 3, 15-HETE; 4, 11-HETE; 5, 12-HETE; 
6, 5-HETE. Chromatographic procedure: RP-HPLC column, Ultra-
sphere-ODS, 250 X 4 mm (Beckman) . Solvent, isocratic elution with 
methanol : water: trifluoroacetic acid: triethylamine 75: 25 : 0.1 : 0.05; 
flow, 1 ml/min. 
Statistics Statistical significance was assessed using two-tailed Student 
t test. A p value below 0.05 was considered significant. 
RESULTS 
A typical chromatogram of prostanoids formed by human dermal 
fibroblasts in culture is shown in Fig 1. A typical RP-HPLC cluo-
matogram of monohydroxy acids formed by dermal fibroblasts is 
shown in Fig 2. Fibroblasts formed PGE2 and PGl2 (determined as 
6-keto-PGF,a) as the major compounds derived from AA. Minor 
compounds such as PGF2a , a non-identified peak, 12-hydroxyepta-
decatrienoic acid (HHT), 15-HETE, and Il-HETE were also 
formed. The identity of 15-HETE was also assessed by means of 
SP-HPLC by coelution with authentic 3H-15-HETE standard, as 
shown in Fig 3. When the fraction corresponding to 15-HETE in 
RP-HPLC was collected and chromatographed again by SP-HPLC, 
a single peak that coeluted with the authentic 15-HETE was ob-
tained. Kinetic experiments showed that the biosynthesis of pros-
tanoids reached a plateau between 100 and 200 11M AA, whereas 
HETE production increased steadily within th e range of AA con-
centrations used (Fig. 4A). To improve the sensitivity ofIL-l assays, 
a suboptimal concentration of AA (25 11M) was chosen. Time course 
experiments showed that the maximum production of prostanoids 
and HETEs took place after about 15 min of incubation (Fig 4B). 
IL-l increased the production of eicosanoids in a concentration-
and time-dependent manner. Results depicted in Figs 5 and 6 show 
that IL-l produced a significant increase in the formation of 15-
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Figure 3. A) RP-HPLC chromatogram of a sample of fibroblasts incubated 
with 25 J.lM I4C_AA (a chromatogram of standards usi ng this procedure is 
shown in Fig 2) . B) RP-HPLC chromatogram of an aliquot of the sample 
showed in (A) plus authentic 3H-15-HETE standard. C) A SP-HPLC cluo-
matogram of the peak corresponding to 15-HETE purified by RP-HPLC 
from an aliquot of the sample showed in (A). D) SP-HPLC chromatogram 
of an al iquot of sample showed in (C) plus authentic 3H-15-HETE standard. 
E) SP-HPLC of unlabeled standards detected by UV absorbance at 234 nm. 
I, 15-HETE; 2, 13-HODE; 3, I1-HETE; 4, 9-HODE; 5, HHT. Chromato-
graphic procedures: RP-HPLC column, Ultrasphere-ODS, 250 X 4 mm 
(Beckman); solvent, isocratic elution with methanol: water: trifluoroacetic 
acid: triethylamine 75: 25 : 0.1: 0.05; flow, 1 ml/min; SP-HPLC column, 
Ultrasphere-Si, 250 X 4 mm (Beckman); solvent, isocratic elution with 
diethyl-cthcr: n-hexane: acetic acid, 30: 70: 0.1; flow, 1 ml/min. 
HETE and I1-HETE in addition to the well~kl1own effect on PGE2 
production. No differences between IL-1a and IL-l p regarding their 
effect on HETE or prostaglandin (PG) -formation were observed. 
Furthermore, the apparent Ka ofIL-l as regards PGs, I1 -HETE, or 
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Figure 4. A) Kinetics ofHETE (sqllares) and prostanoid (circles) production 
by fibroblasts incubated with t 4C_AA for 15 min; n = 3; mean ± SO; B) 
time course of eicosanoid production by fibroblasts incubated with 25 pM 
14C-AA; n = 3; mean ± SO; results are expressed as pmol of AA transformed 
inra each compound by 106 cells. 
15-HETE was similar for both cytokines IL-1Gl' and fJ (IL-IGl': 
0.749 ± 0.36 for PGs, 0.590 ± 0.21 for 11-HETE, 0.630 ± 0.32 
for 15-HETE; IL-1fJ: 0.981 ± 0.41 for PGs, 0.849 ± 0.37 for 11-
HETE, and 0.810 ± 0.36 for 15-HETE; see inserted plots in Fig 6). 
To assess the enzymatic activity involved in the enhancement of 
15-HETE biosynthesis by IL-1, we performed experiments with 
several types of inhibitors. Figure 7 shows the results from actino-
mycin and cycloheximide assays. The blockage of protein biosyn-
thesis totally suppressed the effect of IL-l on HETE and PG pro-
duction. Dexamethasone also suppressed the effect of IL-1 on 
eicosanoid production (Fig 8). The effects of the cyclooxygenase 
inhibitors ASA and indomethacin on HETE and PG production in 
untreated and IL-lp- treated fibroblasts are depicted in Figs 9 and 
10, respectively. ASA totally abolished the synthesis of PGs and 
11-HETE in a dose-dependent manner in both untreated and IL-1 -
treated cells, whereas it was unable to inhibit the synthesis of 15-
HETE even at a concentration of 1000 ,uM. Nevertheless, indo-
methacin inhibited PGs and HETEs in a concentration-dependent 
fashion, and total suppression of the formation of PGs and 11-
HETE was achieved at the 5,uM concentration. For 15-HETE 
strong inhibition was observed at 10,uM indomethacin and total 
suppression was achieved at 25 ,uM drug concentration in both un-
treated and IL-l- treated cells. The treatment with ETY A (a gen-
eral competitive inhibitor of AA oxidation) inhibited the different 
eicosanoids to a similar extent (data not shown). To evaluate the 
contribution of a possible non-enzymatic formation of 1S-HETE in 
ASA-treated cell preparations, 50,uM ETY A was added simulta-
neously with 14C_AA after exposition to ASA. This treatment to-
tally suppressed 1S-HETE production in both untreated and IL-1 -
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Figure 5. Effect oftime of treatment with 10 Vlml of IL-1 ", (A) orIL-1p 
(B) on the formation of prostanoids (circles), 15-HETE (squares), and 11-
HETE (triallgles). n = 4; mean ± SO; results are expressed as pmol of AA 
transformed into each compound by 106 cells after incubation with 25 11M 
"C-AA for 15 min. 
treated cells. When t4C_AA was incubated with boiled cells no 
HETEs or PGs were found . 
The results of inhibition experiments strongly suggested that 
cycIooxygenase was involved in the production of 15-HETE in 
cultured fibrobl asts. To observe the formation of 15-HETE by cy-
cIooxygenase, experiments with isolated enzyme from ram seminal 
vesicles were performed. Figure 2 includes a typical chromatogram 
frol11 an incubation of isolated cycIooxygenase (128 U) with 50,uM 
14C-AA for 5 min, which yielded formation of both lS-HETE and 
11 -HETE. Table I shows the results of inhibition experiments with 
ASA and indomethacin on isolated cyclooxygenase. When isolated 
enzyme was employed, ASA inhibited the synthesis of PGs, 11-
HETE, and 1S-HETE, although the latter to a lesser extent. 
Results regarding the distribution between cytosol and mem-
branes of the lS-HETE, 11-HETE, and PG synthetic activity are 
shown in Table II. The major activity for lS-HETE biosynthesis, 
like for the other eicosanoids, was associated to the membrane frac-
tion in both untreated and IL-lp-treated fibroblasts. 
DISCUSSION 
The biosynthesis of 1S-HETE by dermal fibroblasts in culture had 
been previously reported by Mayer et al [16], who identified this 
compound by using GC-MS. In agreement with Mayer et al [16J, we 
found that in the presence of exogenously added arachidonic acid, 
human dermal fibroblasts synthesize PGs and three monohydroxy 
acids: HHT, Il-HETE, and 15-HETE. In this work the identity of 
1S-HETE has been assessed by coelution with authentic standard by 
using two different chromatographic procedures, which involved 
RP-HPLC and SP-HPLC. 
Our results clearly indicate that IL-l increases the ability of 
human dermal fibroblasts to convert AA into 15-HETE and 11-
HETE in a concentration- and time-dependent fashion. As ex-
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Figure 6. Effect of concentration ofIL-1" (solid circles) or IL-1p (opw circles) 
on AA metabolism in fibroblasts treated with IL-1 for 24 h. A) PGs, B) 
11-HETE, and C) 15-HETE. n = 3; mean ± SE. Results are expressed as 
pmol of AA transformed in every compound by 106 cells after incubation 
with 25 J.lM 14C-AA for 15 min. Inserted plots show the reverse linear 
transformation. Apparent Ka ofIL-l as regards PGs, 11-HETE, or 15-HETE 
was similar for both cytokines IL-la (solid line) and P (dotted litle) . IL-la, 
0.749 ± 0.36 for PGs, 0.590 ± 0.21 for 11-HETE, 0.630 ± 0.32 for 15-
HETE; IL-1P, 0.981 ± 0.41 for PGs, 0.849 ± 0.37 for I1-HETE; and 
0.810 ± 0.36 for 15-HETE. 
pected, IL-l also increased the formation ofPGs, v:-hich is consistent 
with reports from other authors [24-26]. Sl1mlar effect on the 
synthesis of lS-HETE, Il-HETE, or PGs were observed for both 
IL- la and IL-lp. The effect of IL-1 on the synthesis of 15-HETE 
was mediated by de 110110 protein synthesis, as indicated by the fact 
that the treatment of cells with cycloheximide or actinomycin com-
pletely abolished the increase due to the cytokine. The presence of 
dexamethasone also abolished between 80% and 95% of the synthe-
sis of 15-HETE stimulated by IL-1. In all cases, the same results 
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Figure 7. Effect of 3 Jig/ml cycloheximide (CH) or 1 11M actinomycin 0 
(AC) on eicosanoid production by fibroblasts treated with 10 U/ml IL-lp 
for 8 h. Protein inhibitors were incubated together with IL-l. n = 3; 
mean ± SO, results are expressed as pmol of AA transformed into each 
compound by 106 cells after incubation with 25 11M 14C_AA for 15 min (a, 
1/10; h, p < 0.05) . 
were observed regarding the synthesis of 11-HETE and PGs. Dif-
ferent authors [27,31] have postulated that dexamethasone may in-
duce the synthesis of a protein that blocks the translation of the new 
COX induced by IL-1. Our results agree with this hypothesis, as 
dexamethasone only inhibited the increase in th e synthesis of 
eicosanoids induced by IL-1 and showed no significant effect on the 
synthesis of either product in untreated cells. 
Consistent with a cyc100xygenase origin of lS-HETE in dermal 
fibroblasts, indomethacin inhibited 1S-HETE formation in a dose-
dependent fashion, as occurred with I1-HETE and PGs. Hecker et 
all32] reported the ability of pure COX to synthesize 1S-HETE and 
pointed out the possibility that much of the 15-HETE traditionally 
attributed to the 1S-LOX could be due to the COX activity. Similar 
conclusions were obtained by other authors with human umbilical 
arteries and bovine endothelial cells [33,34]. Profound discrepancies 
exist in the literature concerning the inhibition of 15-HETE syn-
thesis by indomethacin in endothelial cells [34,35] and fibroblasts 
[16,36] . However, in reticulocytes and polymorphonuclear cells in 
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Figure 8. Effect of 10 nM dexamethasone (OM) on eicosanoid production 
by fibroblasts treated with 10 U/ml IL-lp for 8 h. DM was incubated to-
gether with IL-l. n = 3; mean ± SO; results are expressed as pmol of All. 
transformed into each compound by 106 cells after incubation with 25 JiM 
14C_AA for 15 min (a, 1/10, b, p < 0.05) . 
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Figure 9. Effect of ASA con-
centration on the synthesis of 
PGs (A), ll-HETE (B), and 
lS-HETE (C) in IL- l -treated 
(sqlwres) and untreated (circles) 
fibrob lasts. Cells were prein-
cuhated at 37 ' C with the in-
hibitors for 10 min before " C_ 
AA addition. 11 = 4; mean ± 
SD; results are expressed as 
pmol of AA transformed into 
each compound by 106 cells 
after incubation with 2511M 
I4C-AA for 15 min. 
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w hich the presence of 1S-LOX has been assessed by immunocyto-
chemical methods [37]' high concentrations of indomethacin (even 
100 .uM) are unable to inhibit the formation of lS-HETE [38,39]. 
Our assays with ASA showed that this drug seems to be a less 
competent inhibitor of lS-HETE than of I1-HETE or PG synthesis 
in fibrobl as ts. These results agree with those recently described by 
Holtzman et al [40] in tracheal bovine epithelial cells. lS-HETE 
biosynthesis by these cells was inhibited by indomethacin but not by 
ASA. Moreover, the treatment with ASA caused a four- to fivefold 
increase in the synthesis of lS-HETE [40]. We observed a similar 
qualitative effect with lOO.uM ASA in IL-l-trea ted fibroblasts. 
T he authors proposed that two COX isoenzymes may exist in tra-
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Figure 10. Effect of indo-
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Table I. Percentage of Inhibition of HETEs or PGs by 1 mM 
ASA or lOO.uM Indomethacin (INDO) as a Function of [AA]/ 
[COX] (.uM/ Ucox/ml)Q 
[AAJ/ [COX) Inhibitor PGs I5-HETE ll-HETE 
ASA 98.4 ± 1.6 92.14±1.8 99.2 ± 1.8 
0.391 INDO 99.95 ± 0.6 95.1 ± 3.8 100 
ASA 95.8 ± 2.3 88.5 ± 7 96.16 ± 2.7 
0.195 INDO 98.75± 1.1 98 ± 1.1 100 
ASA 92.3 ± 2.4 83.8 ± 4 93.47 ± 2.8 
0.098 INDO 97.6 ± 2.2 96.7 ± 3 100 
• 64. 128, or 256 U of isolated cyclooxygenase from raIU seminal vesicles were 
incubated with 50 pM 14C-AA at 37'C fo r 5 min in the presence or the absence of 
inhibitors as described in Materials alld Methods; mea n ± SO; n = 3. 
cheal epithelial cells with different sensitivities to ASA. The appar-
ent discrepancy between the results from ASA and indomethacin 
experiments concerning IS-HETE formation in fibroblasts might 
be explained according to the mechanism of the cyclooxygenase 
reaction. Cyclooxygenase catalyzes the insertion of two molecules 
of oxygen into a molecule of AA. This reaction begins with the 
recognition of the characteristic!entanediene structure, followed 
by the abstraction of an atom 0 hydrogen from carbon 13. The 
electron in C13 can be rearranged through adjacent double bonds, 
mainly to Cl1, yielding PGs and I1-HETE, or to CIS, yielding 
lS-HETE [32] . It is possible that indomethacin and aspirin act on 
different steps of this reaction. Assuming the model proposed by 
Holtzman et al [40], indomethacin would suppress the hydrogen 
abstraction reaction that is the common step in the formation of 
I1 -HETE, PGs, and IS-HETE, whereas ASA would inhibit the 
reaction at a posterior step. ASA suppresses COX activity by acety-
lation ofSerS30 residue and it has been reported that this amino acid 
is not directly involved in the catalysis of the oxidative reaction [41 J. 
It is possible that a small amount of C13-AA radical can be formed 
by acetylated cyclooxygenase and the translocation towards Cll 
could be blocked (as indicated by the inhibition of PGs and 11-
HETE synthesis), whereas electron translocation towards CIS 
could be allowed to a certain degree. It is apparent from our experi-
mental data that ASA inhibits better the products of Cll peroxida-
tion than those of CIS in dermal fibroblas ts. Although to a lesser 
degree, a similar effect is observed by using pure ram seminal vesicle 
cyclooxygenase. 
The activities responsible for the synthesis of both PGs and 
HETEs were mainly found associated with the microsomal fraction 
(100 ,000 Xg pellet). Because COX is a membrane-associated en-
zyme [42J and lS-LOX is cytosolic [43]' these results also support 
the conclusion that IS-HETE is formed basically through the action 
of cyclooxygenase in untreated and in IL-l - treated fibrobl as ts. 
Overall, these results suggest that IL-l increases the production of 
IS-HETE by inducing the synthesis of new cyclooxygenase. 
IL-1 a and IL-l p are preformed in keratinocytes in great amounts, 
and it has been postulated that inflammation of the skin could be 
initiated by the release of this stored IL-l [44] . IL-l displays a num-
Table II. Distribution of the Eicosanoid Biosynthesis Ability 
Between 100,000 X g Supernatant and Pellet' 
Pellet Supernatant 
IL- l - Treated 
Control Control Pellet Supernatant 
l S-HETE 15.1 ±7.3 3.0 ± 4.2 66.2 ± 27.3 3.55 ± 5.02 
I1-HETE 20.1 ± 11.3 ND 93.23 ± 47.1 NO 
PGs 833 ± 323 NO 2090 ± 1579 6 ±9.5 
• Fibroblasts were detaclted with trypsin and disntptcd lUecltanically. After centrifu-
gation at 300 X g for 5 min , supernatant was centrifuged at 100,000 X g at 4 'C for 1 h. 
Supernatant and suspended pellet were tlten incubated with 50 11M " C-AA for 1 0 min; 
mean ± SO; n = 3; results arc expressed as pmol of AA transformed into each com-
pound by 1 mg of protein. 
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ber of pro-inflammatory activities that include induction of the 
release of secondary cytokines with chemotactic and proliferative 
aCtiVItieS, release of PGEz, and increased expression of adhesion 
molecules in the microvascular endothelium [45] . W e report 
herein, for the first time to our knowledge, an increase in 1S-HETE 
production by cultured dermal fibroblasts as a consequence of their 
exposure to IL-l . This observation supports the hypothesis that IL-l 
is also able to downregulate the inflammatory process on skin by 
promoting the formation of anti- inflammatory mediators such as 
lS-HETE (9- 14], which could become accumulated in the in-
flamed tissue. This hypothesis is consistent with the findin g of high 
amounts of 15-HETE in psoriatic lesions (3]. Further research is 
needed to investigate what happens with lS-HETE levels in psori-
atic lesions after administration of cyclooxygenase inhibitors, or 
corticosteroids, which inhibit the effect of several cytokines on the 
expression of cyclooxygenase. Moreover, immunocytochemical 
and/or molecular biology studi es are needed to definitively assess 
the presence of 15-lipoxygenase enzyme in this cell type. 
We wish to thank the stoff oj C/il/ica Pial/as, Barcelollo, Jar tlreir colllribu{ioll oj 
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